How To Get Prescribed A Glp 1 And What To Expect?

Getting prescribed a GLP-1 medication starts with a medical evaluation, not a request. You will need to meet specific clinical criteria — usually a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. A licensed clinician reviews your health history, screens for conditions that make these drugs unsafe, and decides whether to write the prescription. From there, most people wait days to a few weeks for prior authorization, then start at a low dose that increases slowly over several months.

What Is a GLP-1 Medication and How Does It Work?

GLP-1 stands for glucagon-like peptide-1. It is a hormone your gut releases naturally after you eat. The medications mimic that hormone, but at much higher levels and for much longer than your body produces on its own.

The effects are well established. GLP-1 drugs slow how fast food leaves your stomach, which keeps you fuller longer. They act on appetite centers in the brain to reduce hunger. And they improve blood sugar control by prompting the pancreas to release insulin when glucose rises.

Two main categories exist. Semaglutide and liraglutide are GLP-1 receptor agonists. Tirzepatide is a dual agonist — it targets both GLP-1 and GIP, another gut hormone. All are given by injection, though an oral semaglutide tablet is also available for type 2 diabetes and, more recently, for weight management under specific conditions. These are not the same as older weight-loss drugs, and they are not stimulants.

One clarification worth making: these drugs do not “burn fat” directly. Weight loss comes mostly from eating less because appetite and fullness signals change. If a person keeps eating the same amount, the medication will not produce the same result.

Who Qualifies for a GLP-1 Prescription?

Clinical guidelines from major medical organizations define eligibility around BMI and related health conditions. The threshold most clinicians use:

• BMI of 30 or higher — this falls in the obesity range, and GLP-1 medications may be considered for weight management.
• BMI of 27 to 29.9 — this falls in the overweight range, and a prescription may be appropriate if you also have a weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or metabolic syndrome.
• Type 2 diabetes — GLP-1 medications are often prescribed for blood sugar control regardless of BMI, because they lower A1C and carry a lower risk of hypoglycemia than some older diabetes drugs when used alone.

BMI is a crude tool. It does not distinguish muscle from fat or account for where fat sits on the body. Some clinicians also consider waist circumference, metabolic markers, and overall health. But BMI remains the standard most insurance companies and clinical guidelines use to determine coverage.

These medications are not approved for cosmetic weight loss. Someone with a BMI of 24 who wants to lose 10 pounds generally does not meet the criteria. Prescribing outside those criteria is sometimes called off-label use, and many clinicians will not do it.

How Do You Actually Get a Prescription?

The path varies depending on where you live and what kind of clinician you see. Most people get a GLP-1 prescription through one of these routes:

• Primary care doctor. This is the most common starting point. Your doctor knows your history and can screen for contraindications.
• Endocrinologist. A specialist in hormones and metabolism, often involved when type 2 diabetes is the primary reason.
• Obesity medicine specialist. A physician with focused training in weight management.
• Telehealth platforms. Many online services connect you with a clinician who evaluates you remotely. Quality varies widely. Some are legitimate medical practices; others are essentially prescription mills with minimal screening.

During the visit, expect a real conversation about your health history. The clinician should ask about:

• Your weight history and previous weight-loss attempts
• Other medical conditions, especially pancreas, kidney, thyroid, and gallbladder problems
• Family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2) — these are rare but are listed as contraindications
• Current medications, including insulin and sulfonylureas, which can interact
• Pregnancy status or plans to become pregnant
• History of eating disorders

If you have a personal or family history of medullary thyroid cancer or MEN2, GLP-1 medications are generally not recommended. The same applies during pregnancy — these drugs are not recommended while pregnant or breastfeeding, and most guidance suggests stopping them before conception. If you are pregnant or planning to become pregnant, tell your clinician.

Blood work is common. A clinician may check A1C, fasting glucose, kidney function, liver enzymes, and thyroid function before starting.

What Happens After the Prescription Is Written?

Getting the prescription is often not the end of the process. It is the middle. Several things typically happen next.

Prior authorization. Most insurance plans require the clinician to submit documentation showing you meet their criteria. This can take days to weeks. Some plans approve quickly; others deny and require an appeal. Denials are common, especially for weight-management indications.

Pharmacy availability. Some GLP-1 medications have experienced supply shortages in recent years. Your pharmacy may not have your dose in stock. This can delay your start date.

Cost. Without insurance, these medications can cost several hundred to over a thousand dollars per month, depending on the drug and dose. With insurance, copays vary widely. Manufacturer savings programs exist for some products, but eligibility rules apply and they change over time. Check directly with the manufacturer or your pharmacy for current options.

Compounded versions. During shortages, some pharmacies began selling compounded semaglutide or tirzepatide. These are not FDA-approved. The FDA has warned about dosing errors and has stated that compounded versions are not reviewed for safety, effectiveness, or quality the way approved drugs are. Whether compounded versions remain available depends on current FDA rules, which have shifted. This is a fast-moving area — verify the current status before considering this route.

What Should You Expect When You Start Taking It?

Most people start at a low dose. The dose increases slowly over weeks to months. This is deliberate — it lets your body adjust and reduces side effects.

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach pain. These are usually worst in the first few weeks and during dose increases. They often improve as your body adjusts, though not always.

More serious but less common risks include pancreatitis, gallbladder problems, and bowel obstruction. These are rare. The FDA has also required warning labels about a possible risk of thyroid C-cell tumors, based on animal studies. Whether that risk applies to humans has not been confirmed.

Recent research has also examined a possible link between GLP-1 use and a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). The evidence is still emerging. Some studies suggest an association; others do not. This is an active area of research, and no firm conclusion has been reached.

Appetite usually drops within the first week or two. Weight loss typically becomes measurable within the first month. The pace varies widely between individuals. Some people lose steadily; others plateau early. If you stop the medication, appetite often returns and weight is frequently regained. These drugs manage a chronic condition — they do not cure it.

What If You Are Denied or Cannot Afford It?

A denial is not necessarily final. Many insurers approve on appeal when the clinician provides additional documentation. Ask your doctor’s office to submit a prior authorization appeal with detailed clinical justification.

If cost remains a barrier, options include:

• Manufacturer savings programs — check eligibility directly
• Clinical trials — some studies enroll participants and cover medication costs
• Older GLP-1 medications — some are available as generics or at lower cost
• Non-medication approaches — structured lifestyle programs, behavioral counseling, and in some cases bariatric surgery

No clinical guidelines currently exist that recommend one specific alternative over another for people who cannot access GLP-1 medications. The best option depends on your individual health situation and should be discussed with your clinician.